|
|
|
AAP Grand Rounds 3:9-10 (2000) Transplantation-related Immunosuppression Responsible for EBV-related DisordersSource: Ellis D, Jaffe R, Green M, et al. Epstein-Barr Virus-related disorders in children undergoing renal transplantation with tacrolimus-based immunosuppression. Transplantation. 1999;68;9971003.
This paper presents a retrospective analysis of Ebstein-Barr (EBV) associated complications in renal transplant patients at the Childrens Hospital of Pittsburgh treated with an immunosuppressive regimen consisting of tacrolimus (FK506) and prednisone between 19891987. Pre-transplant EBV status was documented for all recipients and for 72% of the donors. By 1995, it was apparent that EBV represented a significant risk for post-transplant complications and so EBV status was prospectively monitored in all patients from then on. The authors divided the patients into 2 groups. Group I consisted of 51 patients who were transplanted from 198995 and group II of 30 patients transplanted after 1995 and in whom EBV studies
|
2008 © COPYRIGHT AMERICAN ACADEMY OF PEDIATRICS. ALL RIGHTS RESERVED.
American Academy of Pediatrics, 141 Northwest Point Blvd., Elk Grove Village, IL, 847-434-4000